NASDAQ: MESO
Mesoblast Ltd Stock Ownership - Who owns Mesoblast?

Insider buying vs selling

Have Mesoblast Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when MESO insiders and whales buy or sell their stock.

MESO Shareholders

What type of owners hold Mesoblast Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc0.06%727,252$7.80MInstitution
Morgan Stanley0.03%402,397$4.31MInstitution
Bank Of America Corp0.03%290,728$3.12MInstitution
Oaktree Capital Management LP0.02%179,593$1.93MInstitution
Ubs Group Ag0.01%168,253$1.80MInstitution
Susquehanna International Group LLP0.01%153,979$1.65MInstitution
Summit X LLC0.01%145,655$1.56MInstitution
Strategic Financial Concepts LLC0.01%138,600$1.49MInstitution
Jane Street Group LLC0.01%102,175$1.10MInstitution
Citigroup Inc0.01%100,000$1.07MInstitution

1 of 3

MESO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MESO0.26%0.00%
GPCR35.24%12.56%Net Buying
CLDX85.28%14.72%Net Buying
EWTX86.39%13.61%Net BuyingNet Buying
LQDA43.22%56.78%Net BuyingNet Selling

Mesoblast Stock Ownership FAQ

Who owns Mesoblast?

Mesoblast (NASDAQ: MESO) is owned by 0.26% institutional shareholders, 0.00% Mesoblast insiders, and 99.74% retail investors. Blackrock Inc is the largest individual Mesoblast shareholder, owning 727,252.00 shares representing 0.06% of the company. Blackrock Inc's Mesoblast shares are currently valued at $7.80M.

If you're new to stock investing, here's how to buy Mesoblast stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.